COR2ED
@COR2EDMedEd • 1,523 subscribers
COR2ED develops and implements high-quality Medical Education programmes for HCPs globally. Explore more via link below ↘️ #MedEd #IME #MedicalEducation
Videos
ER+/HER2- metastatic breast cancer: Highlights from APBCS 2026 Satellite Symposium, chaired by Dr Mastura Md Yusof 📺 Experts discuss 2L+ treatment strategies in endocrine therapy-eligible patients From Dr Hope S. Rugo (Hope Rugo) and Prof. Matteo Lambertini (Matteo Lambertini, MD PhD) This programme has been sponsored by Menarini Stemline and is intended for HCPs only. Brought to you by COR2ED Medical Affairs
COR2ED7,632,504 views • 3 months ago
Personalised treatment in childhood cancer: A journey through 𝘕𝘛𝘙𝘒 fusion testing 📺Video for patients & families – please share with your network From Linet Menachery, patient advocate and mother of a child diagnosed with an 𝘕𝘛𝘙𝘒 fusion-positive pediatric cancer Endorsed by NTRKers, ICAN, International Cancer Advocacy Network & Biomarker Collaborative Supported by an Independent Educational Grant from Bayer
COR2ED5,214,734 views • 3 months ago
Update from ESGO 2026 PYNNACLE Phase 2 study: Interim results from the ovarian cancer cohort Evaluating a first-in-class p53 reactivator, rezatapopt*, in TP53 Y220C–mutant advanced solid tumours 📺 Clinical insights and expert discussion from Profs Domenica Lorusso and Jean-Sebastien Frenel This programme has been sponsored by PMV Pharma and is intended for HCPs only. Brought to you by COR2ED Medical Affairs. *Rezatapopt is an investigational agent which is not approved by a regulatory agency
COR2ED5,788,485 views • 3 months ago
Navigating extrapulmonary neuroendocrine carcinoma (EP-NEC) >> This is a rare and complex cancer that needs early diagnosis and intervention 📺 Watch the video from Meredith Cummins, INCA President-Elect, and CEO of NeuroEndocrine Cancer Australia, to find out: -Why urgency is needed in diagnosis & treatment -The potential of investigational treatments -Where to find support Endorsed by: INCA (NET Cancer Day). NeuroEndocrine Cancer Australia, Neuroendocrine Cancer UK #NotJustNECancer, Neuroendocrine Cancer Foundation, Neuroendocrine Cancer Research Foundation & Minkahz NETs Mission Supported by an Independent Educational Grant from Boehringer Ingelheim
COR2ED757,945 views • 5 months ago
Update on the PYNNACLE Phase 2 initial analysis at AACR–NCI–EORTC 2025 Evaluating rezatapopt, a first-in-class p53 reactivator, as a treatment for TP53 Y220C–mutant locally advanced and metastatic solid tumours Watch the video for expert insights from Drs Alison Schram (Alison Schram) and Elena Garralda *Rezatapopt is an investigational agent which is not approved by a regulatory agency This programme has been sponsored by PMV Pharma
COR2ED710,044 views • 8 months ago
Update from ESMO 2025! >> Endometrial & ovarian cancer highlights 📺 Prof. Nicoletta Colombo reviews the latest data in gynecological cancers presented at the congress Could these developments impact clinical practice? Watch to find out! Endorsed by ICAN, International Cancer Advocacy Network This independent programme is supported by COR2ED
COR2ED114,711 views • 8 months ago
No more content to load